Doshi Dipal 4
4 · Entrada Therapeutics, Inc. · Filed May 20, 2024
Insider Transaction Report
Form 4
Doshi Dipal
DirectorCEO
Transactions
- Sale
Common Stock
2024-05-17$15.11/sh−1,200$18,129→ 337,375 total - Sale
Common Stock
2024-05-16$15.00/sh−1,800$27,000→ 338,575 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.